DocSym
β
Searchsearch
Search
(C88) Malignant immunoproliferative diseases
More details coming soon
161 489 in individuals diagnosis malignant immunoproliferative diseases confirmed
32 609 deaths with diagnosis malignant immunoproliferative diseases
20% mortality rate associated with the disease malignant immunoproliferative diseases
Diagnosis malignant immunoproliferative diseases is diagnosed Men are 19.23% more likely than Women
96 270
Men receive the diagnosis malignant immunoproliferative diseases
20 804 (21.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
65 219
Women receive the diagnosis malignant immunoproliferative diseases
11 805 (18.1 %)Died from this diagnosis.
Risk Group for the Disease malignant immunoproliferative diseases - Men aged 60-64 and Women aged 75-79
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 0-5, 10-24, 35-39
In Women diagnosis is most often set at age 5-9, 25-34, 40-95+
Disease Features malignant immunoproliferative diseases
Absence or low individual and public risk
Malignant immunoproliferative diseases - what does this mean
Malignant immunoproliferative diseases occur when certain white blood cells called lymphocytes grow and divide uncontrollably, leading to an abnormal increase in their numbers and forming tumors in the lymph nodes or other organs. these tumors can then spread to other parts of the body and cause serious health complications.
What happens during the disease - malignant immunoproliferative diseases
Malignant immunoproliferative diseases are a group of disorders characterized by an abnormal proliferation of immune cells caused by a genetic mutation in the gene responsible for regulating the production of these cells. this mutation leads to an overproduction of immune cells, resulting in an accumulation of these cells in the body, leading to an increased risk of infection, organ dysfunction, and other complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant immunoproliferative diseases - Prevention
Malignant immunoproliferative diseases can be prevented by avoiding exposure to certain environmental toxins, maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking and alcohol, and getting vaccinated against certain diseases.